NCT06432920View on ClinicalTrials.gov

A Wearable In-phase Chest Wall Vibration Device for Relief of Dyspnoea in COPD: a First-in-human Exploratory Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

January 26, 2024

Study Completion Date

January 26, 2024

Conditions
Chronic Obstructive Pulmonary DiseaseDyspnea
Interventions
DEVICE

ResWave

Prototype wearable in-phase chest wall vibration device

Trial Locations (1)

D18 AK68

Beacon Hospital, Sandyford

Sponsors

Collaborators (1)

Beacon Hospital
All Listed Sponsors
collaborator

Beacon Hospital

OTHER

lead

Elevre Medical Ltd.

INDUSTRY

NCT06432920 - A Wearable In-phase Chest Wall Vibration Device for Relief of Dyspnoea in COPD: a First-in-human Exploratory Study | Biotech Hunter | Biotech Hunter